This bill proposes the addition of mitragynine synthetic derivatives to the list of Schedule I controlled substances in North Dakota, establishing specific criteria for their classification. It introduces a new subdivision in section 19-03.1-05, which defines various mitragynine synthetic derivatives and sets thresholds for their presence in botanical materials and synthetic products. The bill also amends existing laws regarding penalties for the use and possession of controlled substances, specifically addressing the consequences for individuals who ingest or possess mitragynine synthetic derivatives.

Under the amended provisions, individuals who intentionally ingest mitragynine synthetic derivatives will face an infraction for a first offense and a class A misdemeanor for subsequent offenses. Additionally, the bill modifies penalties for possession, categorizing it as an infraction for a first offense, a class A misdemeanor for a second offense, and a class C felony for a third or subsequent offense. The bill aims to regulate the use of these substances more strictly while providing a clear framework for enforcement and penalties. The act will take effect upon its filing with the secretary of state.

Statutes affected:
INTRODUCED: 19-03.1-22.3, 19-03.1-23